Aimovig 70 MG/ML autoinjectorml
Ended Awarded Last action
- Contract number
- SPE2DR26F0B0J
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,075
Award facts
- Contract value 100% obligated
- $12,074.85 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,074.85 to AmerisourceBergen Drug Corp on January 30, 2026, for the supply of Aimovig 70 mg/ml autoinjectors. This competitive award utilizes firm fixed-price pricing and is structured as a delivery order under an existing contract vehicle. The contract specifies performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of February 2, 2026. This award carries no set-aside designation, indicating it was competed on a full and open basis. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems.
This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), which serves as a comprehensive global pharmaceutical support vehicle. The IDC enables the company to supply an extensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. Aimovig, a migraine prevention treatment, represents one of the specialized pharmaceutical commodities routinely delivered under this strategic contract vehicle to support the Defense Health Agency and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F0B0J?
SPE2DR26F0B0J was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26F0B0J worth?
The government has obligated $12,075 on SPE2DR26F0B0J.
Is contract SPE2DR26F0B0J an order under another contract?
Yes. SPE2DR26F0B0J is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F0B0J competed?
The extent of competition for SPE2DR26F0B0J was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award